pubmed-article:8511230 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8511230 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
pubmed-article:8511230 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
pubmed-article:8511230 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:8511230 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:8511230 | pubmed:dateCreated | 1993-7-15 | lld:pubmed |
pubmed-article:8511230 | pubmed:abstractText | The present report studies the differences between schizophrenic responders and nonresponders within the different symptomatologic groups of the Scale for the Assessment of Negative Symptoms (SANS) and the Scale for the Assessment of Positive Symptoms (SAPS). The relationship between the different electrodermal activity parameters and the scores on the scales was also analyzed. The results showed that nonresponders had negative symptoms. In addition negative symptoms registered a general fall in all electrodermal-activity parameters. | lld:pubmed |
pubmed-article:8511230 | pubmed:language | eng | lld:pubmed |
pubmed-article:8511230 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8511230 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8511230 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8511230 | pubmed:issn | 0254-4962 | lld:pubmed |
pubmed-article:8511230 | pubmed:author | pubmed-author:FuentesII | lld:pubmed |
pubmed-article:8511230 | pubmed:author | pubmed-author:RojoJJ | lld:pubmed |
pubmed-article:8511230 | pubmed:author | pubmed-author:MiquelMM | lld:pubmed |
pubmed-article:8511230 | pubmed:author | pubmed-author:García... | lld:pubmed |
pubmed-article:8511230 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8511230 | pubmed:volume | 26 | lld:pubmed |
pubmed-article:8511230 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8511230 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8511230 | pubmed:pagination | 47-52 | lld:pubmed |
pubmed-article:8511230 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:8511230 | pubmed:meshHeading | pubmed-meshheading:8511230-... | lld:pubmed |
pubmed-article:8511230 | pubmed:meshHeading | pubmed-meshheading:8511230-... | lld:pubmed |
pubmed-article:8511230 | pubmed:meshHeading | pubmed-meshheading:8511230-... | lld:pubmed |
pubmed-article:8511230 | pubmed:meshHeading | pubmed-meshheading:8511230-... | lld:pubmed |
pubmed-article:8511230 | pubmed:meshHeading | pubmed-meshheading:8511230-... | lld:pubmed |
pubmed-article:8511230 | pubmed:meshHeading | pubmed-meshheading:8511230-... | lld:pubmed |
pubmed-article:8511230 | pubmed:meshHeading | pubmed-meshheading:8511230-... | lld:pubmed |
pubmed-article:8511230 | pubmed:meshHeading | pubmed-meshheading:8511230-... | lld:pubmed |
pubmed-article:8511230 | pubmed:meshHeading | pubmed-meshheading:8511230-... | lld:pubmed |
pubmed-article:8511230 | pubmed:year | 1993 | lld:pubmed |
pubmed-article:8511230 | pubmed:articleTitle | Relationships between electrodermal activity and symptomatology in schizophrenia. | lld:pubmed |
pubmed-article:8511230 | pubmed:affiliation | Department of Personality Assessment and Psychologic Treatments, University of Valencia, Spain. | lld:pubmed |
pubmed-article:8511230 | pubmed:publicationType | Journal Article | lld:pubmed |